References
- Alsayed AR, Abu-Samak MS, Alkhatib M. Asthma–COPD overlap in clinical practice (ACO_CP 2023): toward precision medicine. Journal of Personalized Medicine. 2023;13(4): 677. doi:10.3390/jpm13040677
- Bakakos A, Vogli S, Dimakou K, Hillas G. Asthma with fixed airflow obstruction: from fixed to personalized approach. Journal of Personalized Medicine. 2022;12(3):333. doi: 10.3390/jpm12030333.
- Global Initiative for Asthma. Global strategy for asthma management and prevention. 2019. Available from: https://ginasthma.org/reports/2019-gina-report-global-strategy-for-asthma-management-and-prevention/
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2019 report. 2019. Available from: https://goldcopd.org/pocketguidereferences/
- Miravitlles M, Alvarez-Gutierrez FJ, Calle M, Casanova C, Cosio BG, López-Viña A, et al. Algorithm for identification of asthma–COPD overlap: consensus between the Spanish COPD and asthma guidelines. The European Respiratory Journal. 2017;49: 1700068. doi:10.1183/13993003.00068-2017
- Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. The European Respiratory Journal. 2022;60: 2101499. doi:10.1183/13993003.01499-2021
- Zhu M, Chen A. Epidemiological characteristics of asthma–COPD overlap, its association with all-cause mortality, and the mediating role of depressive symptoms: evidence from NHANES 2005–2018. BMC Public Health. 2024;24(1): 1423. doi:10.1186/s12889-024-18911-1
- Rutting S, Thamrin C, Cross TJ, King GG, Tonga KO. Fixed airflow obstruction in asthma: a problem of the whole lung not of just the airways. Frontiers in Physiology. 2022;13: 898208. doi:10.3389/fphys.2022.898208
- World Health Organization. WHO global report on trends in prevalence of tobacco smoking 2000–2025, third edition. Geneva: WHO; 2019. Available from: https://www.who.int/publications/i/item/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-edition
- Althoff MD, Ghincea A, Wood LG, Holguin F, Sharma S. Asthma and three colinear comorbidities: obesity, OSA, and GERD. The Journal of Allergy and Clinical Immunology in Practice. 2021;9(11): 3877–3884. doi:10.1016/j.jaip.2021.09.003
- Chen Z, Ma J, Lei J, Li Y, Zhao R, Zhao L. Fixed airflow obstruction in asthma can be identified early by low FEF25-75% and is associated with environmental exposure. Journal of Asthma and Allergy. 2024;17: 1001–1014. doi:10.2147/jaa.S479215
- Erbay M, Ayçiçek O, Hocek AB, Özdemir KN. The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study. BMC Pulmonary Medicine. 2025;25(1): 291. doi:10.1186/s12890-025-03764-0
- Toumpanakis D, Usmani OS. Small airways in asthma: pathophysiology, identification and management. Chinese Medical Journal Pulmonary and Critical Care Medicine. 2023;1(3): 171–180. doi:10.1016/j.pccm.2023.07.002
- Zhang S, Fan Y, Qin L, Fang X, Zhang C, Yue J, et al. IL-1β augments TGF-β inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics. Respiratory Research. 2021;22(1): 216. doi:10.1186/s12931-021-01808-7
- Markelić I, Hlapčić I, Čeri A, Radić Antolic M, Samaržija M, Popović-Grle S, et al. Activation of NLRP3 inflammasome in stable chronic obstructive pulmonary disease. Scientific Reports. 2022;12(1): 7544. doi:10.1038/s41598-022-11164-1
- Wu Y, Di X, Zhao M, Li H, Bai L, Wang K. The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease. Immunity, Inflammation and Disease. 2022;10(12): e750. doi:10.1002/iid3.750
- Ritzmann F, Lunding LP, Bals R, Wegmann M, Beisswenger C. IL-17 cytokines and chronic lung diseases. Cells. 2022;11(14): 2132. doi:10.3390/cells11142132
- Camargo LDN, Righetti RF, de Almeida FM, Dos Santos TM, Fukuzaki S, Martins NAB, et al. Modulating asthma–COPD overlap responses with IL-17 inhibition. Frontiers in Immunology. 2023;14: 1271342. doi:10.3389/fimmu.2023.1271342
- Kubysheva N, Boldina M, Eliseeva T, Soodaeva S, Klimanov I, Khaletskaya A, et al. Relationship of serum levels of IL-17, IL-18, TNF-α, and lung function parameters in patients with COPD, asthma–COPD overlap, and bronchial asthma. Mediators of Inflammation. 2020;2020: 4652898. doi:10.1155/2020/4652898